The global long read sequencing market utilizes advanced technologies for highly accurate and extensive DNA decoding. Long read sequencing, a transformative genomics approach, overcomes short-read sequencing limitations. It analyzes large genetic stretches, unraveling complex genomic structures and detecting disease-related variations. Also known as third generation sequencing, it involves real-time DNA sequencing, producing long reads without PCR amplification. Key techniques of long read sequencing market value include single molecule real-time (SMRT) sequencing and nanopore sequencing, contributing to a comprehensive understanding of genetic information and driving advancements in genomics.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-long-read-sequencing-market
Data Bridge Market Research analyses that the Global Long Read Sequencing Market value was USD 519.64 million in 2022, and is expected to reach USD 2,533.57 million by 2030, and is expected to undergo a CAGR of 21.9% during the forecast period 2023-2030. Long-read sequencing is pivotal in advancing precision medicine and tailoring treatments to individual genetic variations. This technology enhances our ability to decipher complex genomic information, guiding personalized medical interventions for improved patient outcomes.
Key Findings of the Study
Surge in incidences of genetic disorders is expected to drive the market's growth rate
The rising incidence of genetic disorders, such as sickle cell disease, affecting around 100,000 individuals in the U.S., is a significant driver for the market's growth. As patient numbers increase, key companies will invest in innovative solutions, anticipating market expansion. This surge in genetic disorder cases is expected to draw attention and drive the market's progress shortly, addressing the growing need for advanced diagnostics and therapeutic interventions.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2023 to 2030
|
Base Year
|
2022
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
Segments Covered
|
Technology (Single-Molecule Real- Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing and Others), Product (Instruments, Consumables and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing and Others), Workflow (Pre-Sequencing, Sequencing and Data Analysis), End-User (Academic and Research Institutes, Clinical Laboratories, Hospitals, Pharma and Biotech Entities and Others)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
Market Players Covered
|
Illumina, Inc. (U.S.), MicrobesNG (U.S.), Roche Sequencing (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (U.S.), Oxford Nanopore Technologies plc (U.K.), Quantapore, Inc. (U.S.), FG Technologies (Switzerland), BaseClearB.V (Netherlands), INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY (France), The Garvan Institute (Australia), France Génomique (France), Takara Holdings Inc. (Japan), Genexa AG (Switzerland)
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The global long-read sequencing market is segmented on the basis of technology, product, workflow, application, and end-user.
- On the basis of technology, the global long read sequencing market is segmented into single-molecule real- time sequencing, nanopore sequencing, synthetic long read sequencing, and others
- On the basis of product, the global long read sequencing market is segmented into instruments, consumables and services
- On the basis of workflow, the global long read sequencing market is segmented into pre-sequencing, sequencing and data analysis
- On the basis of application, the global long read sequencing market is segmented into whole genome sequencing, epigenetics, RNA sequencing, complex population, targeted sequencing and others
- On the basis of end-user, the global long read sequencing market is segmented into academic and research institutes, clinical laboratories, hospitals, pharma and biotech entities and others
Major Players
Data Bridge Market Research recognizes the following companies as the major global long read sequencing market players in global long read sequencing market are BaseClearB.V (Netherlands), INSTITUTE OF INTEGRATIVE CELL BIOLOGY AND PHYSIOLOGY (France), France Génomique (France), Takara Holdings Inc. (Japan), Genexa AG (Switzerland)
Market Developments
- 2022年10月，PacBio推出Revio長讀定序系統和Onso短讀定序系統。 Revio 系統整合了深度學習方法，可直接從標準定序庫中檢測 DNA 甲基化，增強該平台提供全面基因組洞察的能力。這些進步表明 PacBio 致力於透過尖端定序技術推動基因組研究
- 2022 年 3 月，Element Biosciences 推出了備受期待的桌上型儀器 Aviti DNA 序列。該技術採用獨特的合成定序化學變化，最大限度地減少了試劑消耗，每千兆位元組的成本約為 7 美元。這項創新標誌著基因組定序在更具成本效益和可近性方面邁出了重要一步，可能會影響各種研究和臨床應用
- 2020年3月，賽默飛世爾科技公司以每股39歐元現金成功收購QIAGEN NV。這項策略性舉措增強了賽默飛世爾科技的產品組合，促進了收入成長並擴大了其全球市場份額。此次收購鞏固了賽默飛世爾在生命科學和診斷領域的地位，增強了其滿足不斷變化的行業需求和向更廣泛的客戶群提供創新解決方案的能力
- 2020年2月，Oxford Nanopore Technologies與NuProbe合作，將Nanopore定序與NuProbe的阻斷劑置換擴增技術結合。此次合作提高了檢測靈敏度，使得能夠對等位基因頻率低於 5% 的體細胞突變進行量化。該策略聯盟拓寬了牛津奈米孔的產品應用，促進了基因組研究和精準醫療的進步
區域分析
從地理上看，全球長讀定序市場報告涵蓋的國家包括北美洲的美國、加拿大和墨西哥，歐洲的德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其，歐洲其他地區，中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓，亞太地區（APAC）的其他地區，沙烏地阿拉伯、阿拉伯聯合大公國、南非、泰國、印尼、菲律賓，亞太地區（APAC）的其他地區，沙烏地阿拉伯、阿聯酋、其他
根據 Data Bridge 市場研究分析：
2023-2030 年預測期內，北美是全球長讀定序市場的主導地區
由於眾多公司、強大的研發能力以及該領域的進步，北美在預測期內佔據全球長讀定序市場的主導地位。該地區在長讀測序領域的強大影響力歸功於關鍵行業參與者的高度集中，這提高了創新和技術創新，使北美成為塑造全球長讀測序格局軌蹟的領導者。
預計在 2023-2030 年預測期內，亞太地區將成為全球長讀定序市場成長最快的地區
預計亞太地區將主導全球長讀定序市場，並在 2023 年至 2030 年期間經歷大幅成長。該地區的加速發展歸功於領導企業向新興亞洲市場的擴張。前瞻性診斷項目的強勁進展也增強了區域市場的實力。這一上升趨勢凸顯了長讀測序技術在推動亞太地區基因組學和診斷學發展方面日益重要的意義。
有關全球長讀測序市場報告的更多詳細信息，請點擊此處 - https://www.databridgemarketresearch.com/reports/global-long-read-sequencing-market
